AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Discovery of Novel Inhibitors of the FKBP51 Protein from a High-throughput Drug Screen
Technology Benefits
First treatment to target FKBP51, All FDA approved compounds, Can be immediately implemented
Detailed Technology Description
Through the use of high-throughput screening University of South Florida researchers have identified several compounds with strong inhibitory activity against FKBP51, which could potentially be immediately implemented into clinics to treat specific patient populations with high levels of FKBP51. These drugs are all FDA approved and could be prescribed off label for the purpose of reducing FKBP51 levels. Patients with elevated levels of FKBP51, specifically those with SNPs in the FKBP5 gene or aged/AD patients, could immediately benefit from receiving drugs that target inhibition of FKBP51.
Country/Region
USA
For more information, please click Here
